Returning to the digital stage this summer, the 2nd JAK Inhibitors Drug Development Summit brings you the only dedicated JAK inhibitor conference that will allow you to utilize the knowledge of the greatest minds and thought leaders within the realms of the JAK pathway across dermatology, rheumatology, gastroenterology, oncology and hematology.

Focusing on optimized selectivity, drug-drug interactions, safety and efficacy challenges, this summit will give you the insight to successfully translate and develop the next generation of superior JAK inhibitors.

Ensure you attend this conference to learn, to network and to strengthen your pipeline, and implement the right clinical strategy.